Drug Design Development And Therapy

Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.

The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.

Specific topics covered by the journal include:

Drug target identification and validation

Phenotypic screening and target deconvolution

Biochemical analyses of drug targets and their pathways

New methods or relevant applications in molecular/drug design and computer-aided drug discovery*

Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)

Structural or molecular biological studies elucidating molecular recognition processes

Fragment-based drug discovery

Pharmaceutical/red biotechnology

Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**

Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development

Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)

Preclinical development studies

Translational animal models

Mechanisms of action and signalling pathways

Toxicology

Gene therapy, cell therapy and immunotherapy

Personalized medicine and pharmacogenomics

Clinical drug evaluation

Patient safety and sustained use of medicines.

《药物设计、开发和治疗》是一本国际性、同行评审、开放获取的期刊，涵盖药物设计、发现和开发直至临床应用的各个领域。

该期刊的特点是快速报道所有治疗领域的高质量原创研究、评论、专家意见、评论和临床研究。

该期刊涵盖的具体主题包括：

药物靶标识别和验证

表型筛选和靶标反卷积

药物靶标及其途径的生化分析

分子/药物设计和计算机辅助药物发现的新方法或相关应用*

新型生物活性化合物的设计、合成和生物学评估（包括诊断或化学探针）

阐明分子识别过程的结构或分子生物学研究

基于片段的药物发现

制药/红色生物技术

天然产物的分离、结构表征、（生物）合成、生物工程和药理学评价**

药物开发中药物或生物活性化合物的分布、药代动力学和代谢转化

药物输送和配方（剂型设计和表征、释放机制和体内测试）

临床前开发研究

转化动物模型

作用机制和信号通路

毒理学

基因治疗、细胞治疗和免疫治疗

个性化医疗和药物基因组学

临床药物评价

患者安全和持续用药。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为4.7，平均审稿速度为 12周，或约稿 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。